Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BenQ Medical Technology's Total Liabilities for the quarter that ended in Dec. 2025 was NT$3,120 Mil.
BenQ Medical Technology's quarterly Total Liabilities
declined
from Jun. 2025 (NT$3,143.10 Mil) to Sep. 2025 (NT$3,029.10 Mil) but then
increased
from Sep. 2025 (NT$3,029.10 Mil) to Dec. 2025 (NT$3,119.86 Mil).
BenQ Medical Technology's annual Total Liabilities
increased
from Dec. 2023 (NT$2,531.83 Mil) to Dec. 2024 (NT$2,973.56 Mil) and
increased
from Dec. 2024 (NT$2,973.56 Mil) to Dec. 2025 (NT$3,119.86 Mil).
BenQ Medical Technology Total Liabilities Related Terms
BenQ Medical Technology Total Liabilities Historical Data
* Premium members only.
The historical data trend for BenQ Medical Technology's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BenQ Medical Technology Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
BenQ Medical Technology's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of NT$3,120 Mil mean?
BenQ Medical Technology (ROCO:4116) has a Total Liabilities of NT$3,120 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for BenQ Medical Technology and its competitors.
Is BenQ Medical Technology's Total Liabilities too high?
BenQ Medical Technology's current Total Liabilities is NT$3,120 Mil. Overall, BenQ Medical Technology has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BenQ Medical Technology's Total Liabilities compare to ISRG and BDX?
BenQ Medical Technology's Total Liabilities of NT$3,120 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for BenQ Medical Technology and its competitors. BenQ Medical Technology's current Total Liabilities is NT$3,120 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, BenQ Medical Technology (ROCO:4116) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$62.38, compared to a current price of NT$38.60 — trading 38.1% below its estimated fair value. The current Total Liabilities is NT$3,120 Mil. BenQ Medical Technology's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For BenQ Medical Technology (ROCO:4116), the current Total Liabilities is NT$3,120 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BenQ Medical Technology (ROCO:4116) Overvalued in 2026?
Based on GuruFocus' analysis, BenQ Medical Technology stock appears to be undervalued.
The current stock price of NT$38.60 is trading 38.1% below its estimated GF Value™ of NT$62.38.
GuruFocus considers BenQ Medical Technology to be Significantly Undervalued.
Key valuation signals for ROCO:4116:
Total Liabilities: NT$3,120 Mil
GF Value™: NT$62.38 vs. price of NT$38.60 (38.1% below fair value)
No single metric tells the full story. See the ROCO:4116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others. The company's segment includes the R&D and Manufacturing Division and the Medical Services Division. The company generates the majority of its revenue from the Medical Services Division. Geographically, the company generates revenue from Taiwan, Mainland China, Indonesia, Thai, India, Colombia, and Others.
81GF Score
Get the complete analysis for ROCO:4116
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4116 has been successfully added to your 
